Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status

por Zhong, Wenzhao, Yang, Xuening, Yan, Honghong, Zhang, Xuchao, Su, Jian, Chen, Zhihong, Liao, Riqiang, Nie, Qiang, Dong, Song, Zhou, Qing, Yang, Jinji, Tu, Haiyan, Wu, Yi-Long
Publicado 2015